Chinese Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

4 companies

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥20.3b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

688266

CN¥76.56

-10.6%

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥22.1b

A biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of cancer and immunological diseases.

688192

CN¥47.53

-11.1%

0.9%

Shenzhen Kangtai Biological Products

Market Cap: CN¥15.5b

Shenzhen Kangtai Biological Products Co., Ltd.

300601

CN¥13.84

-7.4%

-10.4%

Nanjing Vazyme Biotech

Market Cap: CN¥7.9b

Offers technology solutions for life science, biomedicine, and in vitro diagnostics.

688105

CN¥19.77

-6.0%

-12.6%